Showing results (1061-1070 of 3,020) with videos related to
Sort By:
Pageof 302
Current Pharmaceutical Biotechnology|March 21, 2012
X-ray crystallography as a tool for mechanism-of-action studies and drug discoveryEric EnnifarCurrent Pharmaceutical Biotechnology|November 30, 2011
Plant secondary metabolites in cancer chemotherapy: where are we?David M Pereira, Patricia Valentao, Georgina Correia-da-Silva, et al.Current Pharmaceutical Biotechnology|November 30, 2011
Genomics and cancer drug resistanceAntonio S Rodrigues, Joana Dinis, Marta Gromicho, et al.Current Pharmaceutical Biotechnology|November 30, 2011
Genomics and pharmacogenomics of brain disordersRamon Cacabelos, Rocio Martinez-Bouza, Juan Carlos Carril, et al.Current Pharmaceutical Biotechnology|January 28, 2012
Genetics of hypertrophic and dilated cardiomyopathyFelix W Friedrich, Lucie CarrierCurrent Pharmaceutical Biotechnology|January 28, 2012
Understanding the molecular and cellular changes behind aortic valve stenosisInês Falcão-Pires, Cristina Gavina, Adelino F Leite-MoreiraCurrent Pharmaceutical Biotechnology|January 28, 2012
How cardiomyocytes make the heart oldZoltán Papp, Dániel Czuriga, László Balogh, et al.Current Pharmaceutical Biotechnology|January 31, 2012
Selective activation of muscarinic acetylcholine receptors for the treatment of schizophreniaB DeanCurrent Pharmaceutical Biotechnology|January 31, 2012
Subjective well-being of patients with schizophrenia as a target of drug treatmentE Karamatskos, C Mulert, M Lambert, et al.Current Pharmaceutical Biotechnology|January 31, 2012
Pharmacotherapy of schizophrenic patients: achievements, unsolved needs, future research necessitiesHans-Jürgen MollerPageof 302